Amyloid β Protein Monoclonal Antibody
Code No: M046-3
Datasheet:
FID:5527 | PATH:sites/default/files/datasheets/M046-3.PDF
Target:
Amyloid Beta-Protein
Background:
Alzheimer�s disease (AD) is the most common form of dementia in the elderly. The neuropathological hallmarks are neurofibrillary tangles and senile plaques. The major protein component of the plaques is a 39-42 amino acid peptide (?-amyloid/A?). A? occurs in two predominant forms with different COOH-termini, A? 40 and A? 42, and overproduction of A? 42 has been suggested to be the cause of familial early-onset AD. A? generation depends on proteolytic cleavage of the amyloid precursor protein (APP) by two unknown proteases: ?-secretase and ?-secretase. Recent study suggested that a transmembrane aspartic protease, termed beta-site APP-cleaving enzyme (BACE), functionally acts as the ?-secretase. This antibody recognizes N-terminal of A? 40 and A? 42 specifically.
Product Type:
Primary Antibody
Species Reactivities:
Human
Related Products:
M066-3 Amyloid ?/Amyloid Precursor Protein (4E12)
M009-3 Amyloid Precursor Protein (3E9)
References:
1) Saito, A., at al, Proc. Natl. Acad. Sci. USA, 9, 9725-9729 (1994)
2) Bergamaschihi, L., et al, Clin. Exp. Immunol. 115, 526-533 (1999)
3) Vassar R., et al, Science 286, 735-741 (1999).
Formulation:
100 ug IgG in 100 uL volume of PBS containing 50% glycerol, pH 7.2. Contains no preservatives.
Reactivity:
This antibody reacts with synthetic ?- amyloid (1-40) and (1-42) on Western blotting. This antibody does not react with recombinant APP (601-744). Thus this antibody thought to recognize N-terminal of A? (40) and A? (42) specifically.
Intended Use:
For Research use only. Not for use in diagnostic procedure.
|